About ALTOR BIOSCIENCE, LLC
ImmunityBio is a biotechnology company focused on developing immunotherapies to treat cancer and infectious diseases by activating the patient's immune system. The company is advancing investigational therapies, including ANKTIVA®, and has a robust clinical pipeline across multiple therapeutic areas.
Development of investigational immunotherapies that activate both innate and adaptive immune responsesClinical trials in therapeutic areas such as bladder cancer, glioblastoma, HIV, and non-small cell lung cancerPipeline of potential cancer vaccines and immuno-cell therapies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ALTOR BIOSCIENCE, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.